Correlation Between Pasithea Therapeutics and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Pasithea Therapeutics and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Conduit Pharmaceuticals.
Diversification Opportunities for Pasithea Therapeutics and Conduit Pharmaceuticals
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pasithea and Conduit is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Conduit Pharmaceuticals
Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 3.19 times more return on investment than Conduit Pharmaceuticals. However, Pasithea Therapeutics is 3.19 times more volatile than Conduit Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about 0.11 per unit of risk. If you would invest 2.00 in Pasithea Therapeutics Corp on September 12, 2024 and sell it today you would earn a total of 0.50 from holding Pasithea Therapeutics Corp or generate 25.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 68.48% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Pasithea Therapeutics |
| Conduit Pharmaceuticals |
Pasithea Therapeutics and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Conduit Pharmaceuticals
The main advantage of trading using opposite Pasithea Therapeutics and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.The idea behind Pasithea Therapeutics Corp and Conduit Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Conduit Pharmaceuticals vs. Equillium | Conduit Pharmaceuticals vs. DiaMedica Therapeutics | Conduit Pharmaceuticals vs. Valneva SE ADR | Conduit Pharmaceuticals vs. Vivani Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |